FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894964410> ?p ?o ?g. }

• W2894964410 endingPage "1499" @default.
• W2894964410 startingPage "1489" @default.
• W2894964410 abstract "Brain-derived neurotrophic factor (BDNF) and activation of its high affinity receptor tropomyosin kinase (Trk) B promote retinal ganglion cells (RGCs) survival following injury. In this study, we tested the effects of LM22A-4, a small molecule TrkB receptor-specific partial agonist, on RGC survival in vitro and in experimental nonarteritic anterior ischemic optic neuropathy (AION), the most common acute optic neuropathy in those older than 50 years.We assessed drug effects on immunopanned, cultured RGCs and calculated RGC survival and assessed TrkB receptor activation by mitogen-activated protein (MAP) kinase translocation. To assess effects in vivo, we induced murine AION and treated the animals with one intravitreal injection and three-week systemic treatment. We measured drug effects using serial spectral-domain optical coherence tomography (OCT) and quantified retinal Brn3A+ RGC density three weeks after ischemia.In vitro, LM22A-4 significantly increased the survival of cultured RGCs at day 2 (95% CI control: 8.4-13.6; LM22A-4: 23.7-30.3; BDNF: 24.3-29.9; P ≤ 0.0001), similar to the effect of the endogenous TrkB receptor ligand BDNF. There was also significant nuclear and cytoplasmic translocation of MAP kinase (95% CI control: 0.9-6.8; LM22A-4: 38.8-84.4; BDNF: 64.0-93.0; P = 0.0002), a known downstream event of TrkB receptor activation. Following AION, LM22A-4 treatment led to significant preservation of the ganglion cell complex (95% CI: AION-PBS: 66.8-70.7%; AION-LM22A-4: 70.0-73.1; P = 0.03) and total retinal thickness (95% CI: AION-PBS: 185-196%; AION-LM22A-4: 195-203; P = 0.002) as measured by OCT compared with non-treated eyes. There was also significant rescue of the Brn3A+ RGC density on morphometric analysis of whole mount retinae (95% CI control: 2360-2629; AION-PBS: 1647-2008 cells/mm2; AION-LM22A-4: 1958-2216 cells/mm2; P = 0.02).TrkB receptor partial agonist LM22A-4 promoted survival of cultured RGCs in vitro by TrkB receptor activation, and treatment in vivo led to increased survival of RGCs after optic nerve ischemia, providing support that LM22A-4 may be effective therapy to treat ischemic optic neuropathy.AION: anterior ischemic optic neuropathy, BDNF: Brain-derived neurotrophic factor, GCC: ganglion cell complex, MAP: mitogen-activated protein, OCT: spectral-domain optical coherence tomography, OD: right eye, ON: optic nerve, ONH: optic nerve head, OS: left eye, RGC: retinal ganglion cell; Trk: tropomyosin kinase." @default.
• W2894964410 created "2018-10-12" @default.
• W2894964410 creator A5019824956 @default.
• W2894964410 creator A5020390062 @default.
• W2894964410 creator A5027970945 @default.
• W2894964410 creator A5043319544 @default.
• W2894964410 creator A5045601542 @default.
• W2894964410 creator A5050761564 @default.
• W2894964410 creator A5079616106 @default.
• W2894964410 date "2018-10-01" @default.
• W2894964410 modified "2023-09-24" @default.
• W2894964410 title "A Small Molecule TrkB Neurotrophin Receptor Partial Agonist as Possible Treatment for Experimental Nonarteritic Anterior Ischemic Optic Neuropathy" @default.
• W2894964410 cites W141636555 @default.
• W2894964410 cites W1588361932 @default.
• W2894964410 cites W1600830780 @default.
• W2894964410 cites W1821277660 @default.
• W2894964410 cites W1943993932 @default.
• W2894964410 cites W1952281904 @default.
• W2894964410 cites W1967886362 @default.
• W2894964410 cites W1969294711 @default.
• W2894964410 cites W1969811289 @default.
• W2894964410 cites W1970841233 @default.
• W2894964410 cites W1973591584 @default.
• W2894964410 cites W1974612456 @default.
• W2894964410 cites W1975823509 @default.
• W2894964410 cites W1977092589 @default.
• W2894964410 cites W1979702721 @default.
• W2894964410 cites W1981140532 @default.
• W2894964410 cites W1984761401 @default.
• W2894964410 cites W1986504481 @default.
• W2894964410 cites W1991255658 @default.
• W2894964410 cites W1993451440 @default.
• W2894964410 cites W1993628147 @default.
• W2894964410 cites W1994350342 @default.
• W2894964410 cites W1995374378 @default.
• W2894964410 cites W1998183942 @default.
• W2894964410 cites W2000836791 @default.
• W2894964410 cites W2003224205 @default.
• W2894964410 cites W2003395398 @default.
• W2894964410 cites W2006733352 @default.
• W2894964410 cites W2010250841 @default.
• W2894964410 cites W2011261575 @default.
• W2894964410 cites W2011863717 @default.
• W2894964410 cites W2015454021 @default.
• W2894964410 cites W2018976444 @default.
• W2894964410 cites W2023583278 @default.
• W2894964410 cites W2036966153 @default.
• W2894964410 cites W2039127036 @default.
• W2894964410 cites W2043690181 @default.
• W2894964410 cites W2047266336 @default.
• W2894964410 cites W2047392405 @default.
• W2894964410 cites W2049374775 @default.
• W2894964410 cites W2049484831 @default.
• W2894964410 cites W2051901093 @default.
• W2894964410 cites W2053132680 @default.
• W2894964410 cites W2055583081 @default.
• W2894964410 cites W2071603532 @default.
• W2894964410 cites W2071870851 @default.
• W2894964410 cites W2078916806 @default.
• W2894964410 cites W2080980077 @default.
• W2894964410 cites W2081118860 @default.
• W2894964410 cites W2084111299 @default.
• W2894964410 cites W2085330339 @default.
• W2894964410 cites W2093274294 @default.
• W2894964410 cites W2095701055 @default.
• W2894964410 cites W2102274021 @default.
• W2894964410 cites W2110048015 @default.
• W2894964410 cites W2110410747 @default.
• W2894964410 cites W2112978410 @default.
• W2894964410 cites W2140572389 @default.
• W2894964410 cites W2142697079 @default.
• W2894964410 cites W2146399707 @default.
• W2894964410 cites W2146819974 @default.
• W2894964410 cites W2160765822 @default.
• W2894964410 cites W2164591831 @default.
• W2894964410 cites W2331387089 @default.
• W2894964410 cites W2552199680 @default.
• W2894964410 cites W2569472397 @default.
• W2894964410 cites W2745540351 @default.
• W2894964410 cites W2766135107 @default.
• W2894964410 cites W2789787241 @default.
• W2894964410 cites W983974687 @default.
• W2894964410 doi "https://doi.org/10.1080/02713683.2018.1508726" @default.
• W2894964410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30273053" @default.
• W2894964410 hasPublicationYear "2018" @default.
• W2894964410 type Work @default.
• W2894964410 sameAs 2894964410 @default.
• W2894964410 citedByCount "7" @default.
• W2894964410 countsByYear W28949644102019 @default.
• W2894964410 countsByYear W28949644102020 @default.
• W2894964410 countsByYear W28949644102021 @default.
• W2894964410 countsByYear W28949644102023 @default.
• W2894964410 crossrefType "journal-article" @default.
• W2894964410 hasAuthorship W2894964410A5019824956 @default.
• W2894964410 hasAuthorship W2894964410A5020390062 @default.
• W2894964410 hasAuthorship W2894964410A5027970945 @default.
• W2894964410 hasAuthorship W2894964410A5043319544 @default.
• W2894964410 hasAuthorship W2894964410A5045601542 @default.

• next